132 related articles for article (PubMed ID: 14691448)
21. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence.
Tront JS; Hoffman B; Liebermann DA
Cancer Res; 2006 Sep; 66(17):8448-54. PubMed ID: 16951155
[TBL] [Abstract][Full Text] [Related]
22. Transgenic nude mouse with ubiquitous green fluorescent protein expression as a host for human tumors.
Yang M; Reynoso J; Jiang P; Li L; Moossa AR; Hoffman RM
Cancer Res; 2004 Dec; 64(23):8651-6. PubMed ID: 15574773
[TBL] [Abstract][Full Text] [Related]
23. Oncoprotein HCCR-1 expression in breast cancer is well correlated with known breast cancer prognostic factors including the HER2 overexpression, p53 mutation, and ER/PR status.
Ha SA; Lee YS; Shin SM; Kim HK; Kim S; Namkoong H; Kim HJ; Jung SM; Lee YS; Chung YJ; Jung SS; Kim JW
BMC Cancer; 2009 Feb; 9():51. PubMed ID: 19208263
[TBL] [Abstract][Full Text] [Related]
24. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.
Bergmann S; Royer-Pokora B; Fietze E; Jürchott K; Hildebrandt B; Trost D; Leenders F; Claude JC; Theuring F; Bargou R; Dietel M; Royer HD
Cancer Res; 2005 May; 65(10):4078-87. PubMed ID: 15899797
[TBL] [Abstract][Full Text] [Related]
25. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
Shibata MA; Ito Y; Morimoto J; Otsuki Y
Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
[TBL] [Abstract][Full Text] [Related]
26. Mouse models of human breast cancer.
Cardiff RD
Comp Med; 2003 Jun; 53(3):250-3. PubMed ID: 12868567
[No Abstract] [Full Text] [Related]
27. P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.
Ridgeway AG; McMenamin J; Leder P
Oncogene; 2006 Jun; 25(25):3518-27. PubMed ID: 16434961
[TBL] [Abstract][Full Text] [Related]
28. Novel oncogene HCCR: its diagnostic and therapeutic implications for cancer.
Chung YJ; Kim JW
Histol Histopathol; 2005 Jul; 20(3):999-1003. PubMed ID: 15944950
[TBL] [Abstract][Full Text] [Related]
29. Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors.
Faggioli F; Soldati S; Scanziani E; Catò EM; Adorni F; Vezzoni P; Noonan DM; Sacco MG
Breast Cancer Res Treat; 2008 Jul; 110(2):223-6. PubMed ID: 17687642
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.
Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P
Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779
[TBL] [Abstract][Full Text] [Related]
31. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
32. Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.
Alli PM; Pinn ML; Jaffee EM; McFadden JM; Kuhajda FP
Oncogene; 2005 Jan; 24(1):39-46. PubMed ID: 15489885
[TBL] [Abstract][Full Text] [Related]
33. Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland.
Smith AP; Henze M; Lee JA; Osborn KG; Keck JM; Tedesco D; Bortner DM; Rosenberg MP; Reed SI
Oncogene; 2006 Nov; 25(55):7245-59. PubMed ID: 16751806
[TBL] [Abstract][Full Text] [Related]
34. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
[TBL] [Abstract][Full Text] [Related]
35. Mouse models for breast cancer metastasis.
Kim IS; Baek SH
Biochem Biophys Res Commun; 2010 Apr; 394(3):443-7. PubMed ID: 20230796
[TBL] [Abstract][Full Text] [Related]
36. [Advances in study of murine double minute 2/p53 passway with breast cancer].
Ba YH; Li HP
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):551-4. PubMed ID: 17068634
[TBL] [Abstract][Full Text] [Related]
37. New model for hereditary breast cancer.
Hagmann M
Science; 1999 Apr; 284(5415):723, 725. PubMed ID: 10336390
[No Abstract] [Full Text] [Related]
38. Transgenic animals and the study of cancer.
Murphy D
Methods Mol Biol; 1993; 18():23-36. PubMed ID: 21390643
[TBL] [Abstract][Full Text] [Related]
39. Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice.
Zhang D; Shimizu T; Araki N; Hirota T; Yoshie M; Ogawa K; Nakagata N; Takeya M; Saya H
Oncogene; 2008 Jul; 27(31):4305-14. PubMed ID: 18372918
[TBL] [Abstract][Full Text] [Related]
40. [Tissue-specific blocking of the EcoRI site adjacent to the pseudogene for mouse oncoprotein p53].
Ninkina NN; Bukhman VL; Samarina OP; Chumakov PM
Mol Gen Mikrobiol Virusol; 1990 Apr; (4):17-8. PubMed ID: 1973262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
